Trial · NCT02470403
Adverse events535
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 535
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | Part 1: LIK066 150 mg Once Daily (qd) | 12 | 44 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 1: Placebo Once Daily | 5 | 44 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 2: LIK066 75 mg Twice Daily (Bid) | 5 | 40 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 2: LIK066 50 mg Three Times Daily (Tid) | 8 | 43 | |
| other | Abdominal pain | Gastrointestinal disorders | Part 2: Placebo Three Times Daily | 0 | 10 | |
| other | Abdominal pain lower | Gastrointestinal disorders | Part 1: LIK066 150 mg Once Daily (qd) | 3 | 44 | |
| other | Abdominal pain lower | Gastrointestinal disorders | Part 1: Placebo Once Daily | 0 | 44 | |
| other | Abdominal pain lower | Gastrointestinal disorders | Part 2: LIK066 75 mg Twice Daily (Bid) | 1 | 40 | |
| other | Abdominal pain lower | Gastrointestinal disorders | Part 2: LIK066 50 mg Three Times Daily (Tid) | 1 | 43 | |
| other | Abdominal pain lower | Gastrointestinal disorders | Part 2: Placebo Three Times Daily | 0 | 10 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Part 1: LIK066 150 mg Once Daily (qd) | 1 | 44 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Part 1: Placebo Once Daily | 1 | 44 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Part 2: LIK066 75 mg Twice Daily (Bid) | 2 | 40 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Part 2: LIK066 50 mg Three Times Daily (Tid) | 2 | 43 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Part 2: Placebo Three Times Daily | 0 | 10 | |
| other | Abdominal tenderness | Gastrointestinal disorders | Part 1: LIK066 150 mg Once Daily (qd) | 1 | 44 | |
| other | Abdominal tenderness | Gastrointestinal disorders | Part 1: Placebo Once Daily | 0 | 44 | |
| other | Abdominal tenderness | Gastrointestinal disorders | Part 2: LIK066 75 mg Twice Daily (Bid) | 0 | 40 | |
| other | Abdominal tenderness | Gastrointestinal disorders | Part 2: LIK066 50 mg Three Times Daily (Tid) | 2 | 43 | |
| other | Abdominal tenderness | Gastrointestinal disorders | Part 2: Placebo Three Times Daily | 0 | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02470403/events?page=2